APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 67 filers reported holding APTOSE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,186,544 | -9.2% | 4,978,975 | -17.7% | 0.24% | +7.0% |
| Q4 2022 | $3,510,663 | -14.4% | 6,052,867 | -12.1% | 0.23% | -14.0% |
| Q3 2022 | $4,099,000 | -23.6% | 6,888,822 | -4.8% | 0.26% | -1.5% |
| Q2 2022 | $5,367,000 | -46.1% | 7,232,676 | -1.2% | 0.27% | -39.0% |
| Q1 2022 | $9,958,000 | -3.0% | 7,322,189 | -3.7% | 0.44% | +22.2% |
| Q4 2021 | $10,266,000 | -36.0% | 7,604,693 | +3.4% | 0.36% | -28.5% |
| Q3 2021 | $16,035,000 | -36.0% | 7,355,730 | -2.5% | 0.50% | -29.0% |
| Q2 2021 | $25,038,000 | -45.9% | 7,541,497 | -2.6% | 0.71% | -47.4% |
| Q1 2021 | $46,240,000 | +45.2% | 7,738,892 | +6.4% | 1.35% | +37.0% |
| Q4 2020 | $31,854,000 | -22.9% | 7,272,673 | +5.6% | 0.99% | -21.9% |
| Q3 2020 | $41,335,000 | +9.6% | 6,889,157 | +15.3% | 1.26% | +11.2% |
| Q2 2020 | $37,714,000 | +0.8% | 5,976,852 | -5.1% | 1.14% | -18.8% |
| Q1 2020 | $37,417,000 | +9.0% | 6,299,196 | +4.1% | 1.40% | +32.5% |
| Q4 2019 | $34,325,000 | +285.8% | 6,053,830 | +41.9% | 1.06% | +220.3% |
| Q3 2019 | $8,898,000 | -0.1% | 4,267,530 | +25.1% | 0.33% | +20.4% |
| Q2 2019 | $8,905,000 | +7024.0% | 3,412,042 | +5399.6% | 0.27% | +6750.0% |
| Q1 2019 | $125,000 | – | 62,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Annandale Capital, LLC | 74,666 | $209 | 0.05% |
| CALDWELL SUTTER CAPITAL, INC. | 92 | $258 | 0.00% |